- Tytuł:
- Pan-Genotypic Hepatitis C Treatment with Glecaprevir and Pibrentasvir for 8 Weeks Resulted in Improved Cardiovascular and Metabolic Outcomes and Stable Renal Function: A Post-Hoc Analysis of Phase 3 Clinical Trials.
- Autorzy:
- Źródło:
- Infectious Diseases & Therapy. Dec2018, Vol. 7 Issue 4, p473-484. 12p.
Czasopismo naukowe